Skip to main content
Search
Search
Anywhere
Quick Search anywhere
Enter words / phrases / DOI / ISBN / keywords / authors / etc
Search
Advanced Search
Login
Skip main navigation
Open Drawer Menu
Close Drawer Menu
Home
Journal of Comparative Effectiveness Research
Journal of Patient Centricity
The Evidence Base
Skip slideshow
Journal of Comparative Effectiveness Research
ISSN (print): 2042-6305 • ISSN (online): 2042-6313
Impact Factor: 2.8 (2025) • CiteScore: 4.2 (2025) • Open Access
Read more
Journal of Patient Centricity
ISSN (online): 2978-8579
In partnership with the PCSIG • Open Access
Read more
The Evidence Base
Latest news, opinion and insight into hot topics including RWE, HEOR, HTA and market access
Read more
Latest
Patient centricity must become the default, not the exception
James Rudge
Journal of Patient Centricity
3 Nov 2026
The impact of sequential analysis on drug decision-making in Canada
Catherine Beauchemin
,
Jean Lachaine
,
Jean-Eric Tarride
,
Ana Rusu
, and
Stephane Barakat
Journal of Comparative Effectiveness Research
27 Oct 2026
As AI becomes more autonomous, where does human oversight need to remain? Sessions on the agenda at ISPOR Europe 2026
The Evidence Base
4 Nov 2026
What the first year of EU JCA reveals about comparative effectiveness and value assessment: An interview with Huseyin Naci, LSE Health
The Evidence Base
4 Nov 2026
Journal of Comparative Effectiveness Research
Open access, peer-reviewed journal offering rapid publication for all aspects of HEOR and related areas
Read More
FROM THE EVIDENCE BASE
4 Nov 2026
As AI becomes more autonomous, where does human oversight need to remain? Sessions on the agenda at ISPOR Europe 2026
3 Nov 2026
Industry update tracker: October 2026
3 Nov 2026
What will it take for RWE to become decision-grade? Sessions on the agenda at ISPOR Europe 2026
4 Nov 2026
As AI becomes more autonomous, where does human oversight need to remain? Sessions on the agenda at ISPOR Europe 2026
3 Nov 2026
What will it take for RWE to become decision-grade? Sessions on the agenda at ISPOR Europe 2026
2 Nov 2026
One year into JCA, what have we learned and what comes next? Sessions on the agenda at ISPOR Europe 2026
4 Nov 2026
As AI becomes more autonomous, where does human oversight need to remain? Sessions on the agenda at ISPOR Europe 2026
3 Nov 2026
Industry update tracker: October 2026
2 Nov 2026
One year into JCA, what have we learned and what comes next? Sessions on the agenda at ISPOR Europe 2026
The Evidence Base
Online hub providing the latest news, opinion and insights into HEOR, RWE, HTA and more
Read More
FROM THE EVIDENCE BASE
4 Nov 2026
As AI becomes more autonomous, where does human oversight need to remain? Sessions on the agenda at ISPOR Europe 2026
4 Nov 2026
What the first year of EU JCA reveals about comparative effectiveness and value assessment: An interview with Huseyin Naci, LSE Health
4 Nov 2026
Connecting JCA evidence needs with the target trial framework
3 Nov 2026
Industry update tracker: October 2026